Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 189

Results For "INST"

3147 News Found

Nikon India forays into the Indian healthcare sector
News | November 15, 2022

Nikon India forays into the Indian healthcare sector

Nikon’s newly launched product AXR Point scanning confocal microscope provides “World’s largest Field of View” of 25mm in one single shot


GL Chemtech appoints Dr. John Warner as Green Chemistry Innovation Advisor
People | November 14, 2022

GL Chemtech appoints Dr. John Warner as Green Chemistry Innovation Advisor

Reinforcing GLC’s commitment to sustainable processing in pharmaceutical chemistry


Suven Life Sciences posts Q2FY23 consolidated loss at Rs. 23.18 Cr
News | November 14, 2022

Suven Life Sciences posts Q2FY23 consolidated loss at Rs. 23.18 Cr

The company has reported total income of Rs. 4.59 crores during the period ended September 30, 2022


Supriya Lifescience Q2 FY2023 profit slips to Rs. 16.86 Cr
News | November 14, 2022

Supriya Lifescience Q2 FY2023 profit slips to Rs. 16.86 Cr

The company has reported total income of Rs. 114.77 crores during the period ended September 30, 2022.


Aurobindo Pharma Q2 FY23 revenue down 3.4%
News | November 14, 2022

Aurobindo Pharma Q2 FY23 revenue down 3.4%

Formulation revenue decreased by 7.6% YoY to Rs. 4,770 crore whereas in Q2 FY23, API business posted a growth of 24.2% YoY with revenue of Rs. 969.4 crore


Sanofi, GSK’s next-generation COVID-19 booster vaccine approved by the European Commission
Drug Approval | November 11, 2022

Sanofi, GSK’s next-generation COVID-19 booster vaccine approved by the European Commission

First and only next-generation protein-based adjuvanted COVID-19 booster approved in Europe


Jagsonpal Pharmaceuticals reports Q2FY23 net profit at Rs. 10.41 Cr
News | November 11, 2022

Jagsonpal Pharmaceuticals reports Q2FY23 net profit at Rs. 10.41 Cr

The company has reported total income of Rs. 61.64 crores during the period ended September 30, 2022.


Pfizer and BioNTech receive positive CHMP opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster
Drug Approval | November 11, 2022

Pfizer and BioNTech receive positive CHMP opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster

The European Commission will review the CHMP recommendation and is expected to make a final decision soon.


YS Biopharma announces USFDA clearance of IND Application for PIKA COVID-19 vaccine
Drug Approval | November 11, 2022

YS Biopharma announces USFDA clearance of IND Application for PIKA COVID-19 vaccine

PIKA COVID-19 vaccine is currently in Phase 3, multi-country, multi-center clinical trial conducted at Southeast Asian and Middle East countries.


Centre deploys high level team to Mumbai to take stock of Measles cases
News | November 10, 2022

Centre deploys high level team to Mumbai to take stock of Measles cases

The team will assist the State Health Authorities in instituting public health measures and facilitate operationalization of requisite control and containment measures